Mirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosedFC
Farallon Capital Management
Activity from announced rounds
Activity in this selectionSeries B
Farallon Capital Management is the investment manager identified by Encoded Therapeutics and HiBob, with Farallon also used as a short name.
Recorded funding activity
Encoded develops precision gene therapies for neurological disorders. HiBob supplies the Bob people-management platform, while Mirador develops medicines for inflammatory and fibrotic diseases. Their financing events retain the same manager identity without collapsing individual funds.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $250M 1 disclosed · full round size, not this investor’s share